MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,026,068 | +4.5% | 57,648 | +0.5% | 0.01% | +14.3% |
| Q2 2022 | $3,851,893 | -19.9% | 57,378 | -1.9% | 0.01% | 0.0% |
| Q1 2022 | $4,808,113 | +12.1% | 58,480 | +100.0% | 0.01% | -36.4% |
| Q4 2021 | $4,289,000 | -16.1% | 29,241 | +1.2% | 0.01% | -21.4% |
| Q3 2021 | $5,112,000 | -43.1% | 28,894 | -48.1% | 0.01% | +7.7% |
| Q2 2021 | $8,988,000 | +75.3% | 55,642 | +85.9% | 0.01% | -18.8% |
| Q1 2021 | $5,127,000 | -30.7% | 29,931 | -11.1% | 0.02% | -30.4% |
| Q4 2020 | $7,398,000 | +37.1% | 33,683 | +3.6% | 0.02% | +15.0% |
| Q3 2020 | $5,397,000 | -27.9% | 32,501 | -50.5% | 0.02% | +33.3% |
| Q2 2020 | $7,490,000 | +78.9% | 65,606 | +20.5% | 0.02% | +50.0% |
| Q1 2020 | $4,186,000 | -44.1% | 54,464 | -6.3% | 0.01% | -33.3% |
| Q4 2019 | $7,488,000 | +69.6% | 58,102 | +2.6% | 0.02% | +66.7% |
| Q3 2019 | $4,414,000 | -24.5% | 56,654 | -0.2% | 0.01% | -18.2% |
| Q2 2019 | $5,844,000 | – | 56,740 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |